JUAN JOSÉ
POZA ALDEA
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (8)
2024
-
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis
Acta Neuropathologica, Vol. 148, Núm. 1
2020
-
Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study
European Journal of Neurology, Vol. 27, Núm. 8, pp. 1364-1373
-
Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain
Genes, Vol. 11, Núm. 5
2018
-
Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis
Journal of the Neurological Sciences
-
Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area
Neurologia, Vol. 33, Núm. 9, pp. 583-589
2016
-
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Progress in Neurobiology, Vol. 142, pp. 104-129
-
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Neurology, Vol. 87, Núm. 12, pp. 1250-1257
2013
-
The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism
Journal of Molecular Medicine, Vol. 91, Núm. 12, pp. 1399-1406